HER2 Oncogenic Function Escapes EGFR Tyrosine Kinase Inhibitors via Activation of Alternative HER Receptors in Breast Cancer Cells
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference46 articles.
1. The epidermal growth factor receptor family.;LA Bazley;Endocr Relat Cancer,2005
2. Untangling the ErbB signalling network.;Y Yarden;Nat Rev Mol Cell Biol,2001
3. EGF-ERBB signalling: towards the systems level.;A Citri;Nat Rev Mol Cell Biol,2006
4. The ErbB signaling network: receptor heterodimerization in development and cancer.;MA Olayioye;Embo J,2000
5. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.;EE Cohen;J Clin Oncol,2003
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Radiotherapy Plus Cisplatin With or Without Lapatinib for Non–Human Papillomavirus Head and Neck Carcinoma;JAMA Oncology;2023-11-01
2. Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma;Molecular Oncology;2023-07-14
3. Dual kinase inhibitor for EGFR mutants and ErbB2 limit breast cancer;Biochemical and Biophysical Research Communications;2023-04
4. Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer;Drug Resistance Updates;2022-12
5. Head and neck squamous cell carcinoma: Exploring frontiers of combinatorial approaches with tyrosine kinase inhibitors and immune checkpoint therapy;Critical Reviews in Oncology/Hematology;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3